.. | ||
hnpcc.molgen.TA | ||
hnpcc.molgen.TB | ||
hnpcc.T.cancer_risks_by_gene_in_individu | ||
hnpcc.T.hereditary_cancer_syndromes_with | ||
hnpcc.T.lynch_syndrome_genespecific_labo | ||
hnpcc.T.lynch_syndrome_notable_pathogeni | ||
hnpcc.T.molecular_genetic_testing_used_i | ||
hnpcc.T.most_prevalent_known_variants_as | ||
hnpcc.T.recommended_evaluations_followin | ||
hnpcc.T.recommended_surveillance_for_ind | ||
hnpcc.T.treatment_of_manifestations_in_i | ||
hnpcc.T.tumor_tissue_test_results_interp |